Gentherm to combine with Modine unit; $2.6B pro forma day‑one
Gentherm (THRM) described a proposed combination with Modine’s Performance Technologies via a Reverse Morris Trust that would create a larger thermal and flow-management platform.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gentherm (THRM) described a proposed combination with Modine’s Performance Technologies via a Reverse Morris Trust that would create a larger thermal and flow-management platform. Management said the deal would make Gentherm a roughly $2.6 billion company on day one with $320 million of EBITDA and outlined a path to about $3.4–$3.5 billion and >$520 million of EBITDA by 2030. Executives expect close in early Q4, have an integration management office in place, and identified product and geographic cross-sell opportunities (power generation, commercial/off-highway, India, home and office). They reiterated organic growth drivers: automotive program launches, lumbar/massage adoption, China strength, a $100 million furniture adjacency by 2028, and medical product ThermAffyx entering production in July. Management noted a $20 million cost headwind and inventory/footprint transitions affecting near-term margins, and said pro forma leverage would be about one turn after closing.
Insights
Deal framed as scale-and-diversification via a Reverse Morris Trust, creating cross-sell and geographic reach.
Management positions the transaction to add Modine as a stand‑alone division with its management intact, citing complementary thermal and flow technologies and access to non‑light‑vehicle end markets such as power generation, commercial/off‑highway and India manufacturing footprint.
Key execution dependencies are the timing of regulatory and shareholder approvals, the integration of corporate functions (treasury, IT, tax) and realization of the cited revenue synergies; management targets closing in early Q4 and describes an integration management office already active.
Transaction structure aims to preserve balance sheet flexibility with ~1x pro forma leverage and optionality for M&A or buybacks.
The team says the Reverse Morris Trust includes equity and a distribution component, leaving Gentherm roughly one turn levered post‑close, which they expect will support tuck‑ins or share repurchases. Management flagged a $20 million cost headwind and inventory/footprint transition pressure through mid‑2026.
Monitor filings (Form S‑4, Form 10) for transaction terms, pro forma leverage detail, adjusted EBITDA reconciliations and any closing conditions or covenants that affect capital allocation flexibility.
Key Figures
Key Terms
Reverse Morris Trust regulatory
Form S-4 regulatory
510(k) regulatory
Adjusted EBITDA financial
integration management office operational
BOM technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the proposed Gentherm (THRM) transaction with Modine?
When do Gentherm executives expect the Modine deal to close?
What are the near‑term financial targets cited for the combined company?
What is ThermAffyx and when will it enter production?
How does Gentherm expect to generate revenue synergies with Modine?
AI-generated analysis. How Rhea-AI works. Not financial advice.